Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2005 1
2006 1
2008 2
2009 1
2010 3
2012 1
2013 3
2014 4
2015 2
2016 2
2017 2
2018 2
2019 4
2020 5
2021 3
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Vaccines and immunization against human papillomavirus.
Christensen ND, Budgeon LR. Christensen ND, et al. Curr Probl Dermatol. 2014;45:252-64. doi: 10.1159/000356183. Epub 2014 Mar 13. Curr Probl Dermatol. 2014. PMID: 24643192
Prophylactic and therapeutic immunization strategies are an effective method to control human papillomavirus (HPV)-associated diseases and cancers. Current protective virus-like particle and capsid-based vaccines are highly protective against vaccine-m …
Prophylactic and therapeutic immunization strategies are an effective method to control human papillomavirus (HPV)-associated …
Natural and synthetic drugs and formulations for intravaginal HPV clearance.
Khamjan NA, Beigh S, Algaissi A, Megha K, Lohani M, Darraj M, Kamli N, Madkhali F, Dar SA. Khamjan NA, et al. J Infect Public Health. 2023 Sep;16(9):1471-1480. doi: 10.1016/j.jiph.2023.06.016. Epub 2023 Jun 26. J Infect Public Health. 2023. PMID: 37535995 Free article. Review.
BACKGROUND: Except for a few preventative Human Papillomavirus (HPV) vaccines, there is currently no cure for HPV infection. There are a number of cutting-edge strategies and potent medications or herbal formulations that can be applied topically for early …
BACKGROUND: Except for a few preventative Human Papillomavirus (HPV) vaccines, there is currently no cure for HPV infec …
Current strategies against persistent human papillomavirus infection (Review).
Liu Y, Li H, Pi R, Yang Y, Zhao X, Qi X. Liu Y, et al. Int J Oncol. 2019 Sep;55(3):570-584. doi: 10.3892/ijo.2019.4847. Epub 2019 Jul 23. Int J Oncol. 2019. PMID: 31364734 Review.
Human papillomavirus (HPV) is the most common sexually transmitted infection, exhibiting a tropism for the epidermis and mucosae. ...In this article, the life cycle of HPV, the mechanisms facilitating HPV evasion of recognition and clearance by the host immun …
Human papillomavirus (HPV) is the most common sexually transmitted infection, exhibiting a tropism for the epidermis and mucos …
Why Human Papillomavirus Acute Infections Matter.
Alizon S, Murall CL, Bravo IG. Alizon S, et al. Viruses. 2017 Oct 10;9(10):293. doi: 10.3390/v9100293. Viruses. 2017. PMID: 28994707 Free PMC article. Review.
Most infections by human papillomaviruses (HPVs) are `acute', that is non-persistent. ...From a dynamical perspective, adopting concepts from spatial ecology, such as meta-populations or meta-communities, can help explain why HPV acute infections sometimes last for years. …
Most infections by human papillomaviruses (HPVs) are `acute', that is non-persistent. ...From a dynamical perspective, adopting conce …
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT, Wang JW, Peng S, Huang TC, Wang C, Cannella F, Chang YN, Viscidi RP, Best SRA, Hung CF, Roden RBS. Jiang RT, et al. J Virol. 2017 Jul 12;91(15):e00699-17. doi: 10.1128/JVI.00699-17. Print 2017 Aug 1. J Virol. 2017. PMID: 28515303 Free PMC article.
A human papillomavirus 16 (HPV16)-targeted version of the DNA vaccine also induced L2 antibodies and protected mice from vaginal challenge with an HPV16 pseudovirus. ...The strict tropism of HPV requires the use of animal papillomavirus models for ther …
A human papillomavirus 16 (HPV16)-targeted version of the DNA vaccine also induced L2 antibodies and protected mice fro …
Cervical cancer heterogeneity: a constant battle against viruses and drugs.
Sun Q, Wang L, Zhang C, Hong Z, Han Z. Sun Q, et al. Biomark Res. 2022 Nov 17;10(1):85. doi: 10.1186/s40364-022-00428-7. Biomark Res. 2022. PMID: 36397138 Free PMC article. Review.
Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the most promising malignancy to be eliminated. ...Tumor heterogeneity exists in various aspects including the immune clearance of viruses, tumorigenesis, neoplasm …
Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the most promising malignancy to be e …
Therapy of human papillomavirus-related disease.
Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH. Stern PL, et al. Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F71-82. doi: 10.1016/j.vaccine.2012.05.091. Vaccine. 2012. PMID: 23199967 Free PMC article. Review.
This chapter reviews the current treatment of chronic and neoplastic human papillomavirus (HPV)-associated conditions and the development of novel therapeutic approaches. ...Treatments that can shift the balance of immune effectors locally in combination with vac …
This chapter reviews the current treatment of chronic and neoplastic human papillomavirus (HPV)-associated conditions and the …
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML, Meadows J, Doré CJ, Copas AJ, Haddow LJ, Lacey C, Jit M, Soldan K, Bennett K, Tetlow M, Nathan M, Gilson R. Murray ML, et al. BMC Med Res Methodol. 2018 Nov 6;18(1):125. doi: 10.1186/s12874-018-0581-z. BMC Med Res Methodol. 2018. PMID: 30400777 Free PMC article. Clinical Trial.
BACKGROUND: Anogenital warts are the second most common sexually transmitted infection diagnosed in sexual health services in England. About 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, and half of episodes diagnosed are recurrences. …
BACKGROUND: Anogenital warts are the second most common sexually transmitted infection diagnosed in sexual health services in England. About …
Carrageenan as a Preventive Agent Against Human Papillomavirus Infection: A Narrative Review.
Laurie C, El-Zein M, Coutlée F, de Pokomandy A, Franco EL. Laurie C, et al. Sex Transm Dis. 2021 Jul 1;48(7):458-465. doi: 10.1097/OLQ.0000000000001363. Sex Transm Dis. 2021. PMID: 33433173 Review.
Carrageenan, an extract from red algae, was identified over a decade ago as a potent inhibitor of human papillomavirus (HPV) infection in vitro. After this discovery, several studies evaluated carrageenan's anti-HPV activity in cells, experimental animals, and human …
Carrageenan, an extract from red algae, was identified over a decade ago as a potent inhibitor of human papillomavirus (HPV) i …
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R, Nugent D, Bennett K, Doré CJ, Murray ML, Meadows J, Haddow LJ, Lacey C, Sandmann F, Jit M, Soldan K, Tetlow M, Caverly E, Nathan M, Copas AJ. Gilson R, et al. Health Technol Assess. 2020 Sep;24(47):1-86. doi: 10.3310/hta24470. Health Technol Assess. 2020. PMID: 32975189 Free PMC article. Clinical Trial.
Podophyllotoxin plus quadrivalent human papillomavirus vaccine had inconclusive cost-effectiveness compared with podophyllotoxin alone. ...Podophyllotoxin without quadrivalent human papillomavirus vaccine is the most cost-effective strate …
Podophyllotoxin plus quadrivalent human papillomavirus vaccine had inconclusive cost-effectiveness compared with podoph …
41 results